The pro-inflammatory cytokine environment in IBD, involving molecules like TNF-α, IL-6, and IL-1β, appears to exacerbate insulin resistance, especially in older individuals who may already be more vulnerable to metabolic disturbances. Here, IL1B is linked to inflammatory bowel disease.